Attenuated PDGF signaling drives alveolar and microvascular defects in neonatal chronic lung disease
Authors:
Open Access
- 18 September 2017
- journal article
- Published by Springer Nature in EMBO Molecular Medicine
- Vol. 9 (11) , 1504-1520
Abstract
Neonatal chronic lung disease (nCLD) affects a significant number of neonates receiving mechanical ventilation with oxygen‐rich gas (MV‐O2). Regardless, the primary molecular driver of the disease remains elusive. We discover significant enrichment for SNPs in the PDGF‐Rα gene in preterms with nCLD and directly test the effect of PDGF‐Rα haploinsufficiency on the development of nCLD using a preclinical mouse model of MV‐O2. In the context of MV‐O2, attenuated PDGF signaling independently contributes to defective septation and endothelial cell apoptosis stemming from a PDGF‐Rα‐dependent reduction in lung VEGF‐A. TGF‐β contributes to the PDGF‐Rα‐dependent decrease in myofibroblast function. Remarkably, endotracheal treatment with exogenous PDGF‐A rescues both the lung defects in haploinsufficient mice undergoing MV‐O2. Overall, our results establish attenuated PDGF signaling as an important driver of nCLD pathology with provision of PDGF‐A as a protective strategy for newborns undergoing MV‐O2. Synopsis A genetic approach in a neonatal mouse ventilation model shows that PDGFRA haploinsufficiency is sufficient to produce neonatal chronic lung disease (nCLD)‐like pathology, and that therapeutic ligand provision can rescue these defects. Mechanical ventilation with oxygen‐rich gas (MV‐O2) results in attenuated signaling via PDGFRA in myofibroblasts in part due to an effect of TGF‐β, resulting in impaired secondary septation and reduced expression of VEGF‐A with increased endothelial cell apoptosis, cardinal features of nCLD. PDGFRA‐haploinsufficiency in mice confers enhanced susceptibility to development of nCLD with MV‐O2, which can be rescued by endotracheal provision of exogenous PDGF. Human preterm infants with nCLD show significant enrichment for SNPs in the PDGFRA gene associated with reduced protein level expression of PDGFRA and impaired lung myofibroblast activity.Keywords
Funding Information
- Deutsche Forschungsgemeinschaft (HI 1315/5‐1)
- Bundesministerium für Forschung, Technologie und Raumfahrt (01KI1010C)
- Bundesministerium für Forschung, Technologie und Raumfahrt (01KI1010I)
- Helmholtz-Gemeinschaft (NWG VH‐NG‐829)
This publication has 44 references indexed in Scilit:
- Targeting VEGF-VEGFR Pathway by Sunitinib in Peripheral Primitive Neuroectodermal Tumor, Paraganglioma and Epithelioid Hemangioendothelioma: Three Case ReportsCase Reports in Oncology, 2013
- Targeting the PDGF signaling pathway in tumor treatmentCell Communication and Signaling, 2013
- Inhibiting Lung Elastase Activity Enables Lung Growth in Mechanically Ventilated Newborn MiceAmerican Journal of Respiratory and Critical Care Medicine, 2011
- The new bronchopulmonary dysplasiaCurrent Opinion in Pediatrics, 2011
- Long-term failure of alveologenesis after an early short-term exposure to a PDGF-receptor antagonistAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2011
- Platelet-derived growth factor (PDGF)–PDGF receptor interaction activates bone marrow–derived mesenchymal stromal cells derived from chronic lymphocytic leukemia: implications for an angiogenic switchBlood, 2010
- Mechanical ventilation uncouples synthesis and assembly of elastin and increases apoptosis in lungs of newborn mice.American Journal of Physiology-Lung Cellular and Molecular Physiology, 2008
- The STATs of cancer — new molecular targets come of ageNature Reviews Cancer, 2004
- Evolutionary Divergence of Platelet-Derived Growth Factor Alpha Receptor Signaling MechanismsMolecular and Cellular Biology, 2003
- Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesisOncogene, 2002